Toggle navigation
About
Mission
Team
Careers
Our Science
Adaptive Stress
Innate and Adaptive Immunity
QuAD3 Platform
Programs
Pipeline
Stress Modulator
Platform
Innate and Adaptive
Immune Modulator
Patients & Caregivers
News & Publications
Contact
About
Mission
Team
Careers
Our Science
Adaptive Stress
Innate and Adaptive Immunity
QuAD3 Platform
Programs
Pipeline
Stress Modulator
Platform
Innate and Adaptive
Immune Modulator
Patients & Caregivers
News & Publications
Contact
News & Publications
News & Publications
News & Publications
11.01.19
|
publication
Association of immunopharmacodynamic responses of Imprime PGG plus pembrolizumab with clinical benefit in metastatic triple negative breast cancer (TNBC) subjects failing front-line chemotherapy